Background
HIV-1 disproportionately affects minority groups, including transgender individuals, in the USA. Masculinizing hormonal therapy, integral to gender-affirming care for transgender men (TGM), has immunomodulatory properties that heighten HIV-1 acquisition risk. Testosterone activates both myeloid and lymphoid cells through androgen receptors (ARs), resulting in a shift in the cytokine milieu and a defective innate immune response. The cervical mucosae are enriched with HIV-1 target cells inclusive of macrophages and CD4+ T cells that co-express ARs. The extent to which this impacts HIV-1 vulnerability in TGM remains unclear.
Methods
We investigated the impact of hormonal therapy on HIV-1 target cells, in an ex vivo model of HIV infection using cervical tissue explants (CETs). CETs obtained from TGM and cis gender women (CIS) undergoing medically indicated hysterectomies were sectioned into 2 mm3 blocks. These were inoculated with subtype A and D transmitted founder (T/F) infectious molecular clones (IMCs) engineered to express secreted nano-luciferase (snLuc) or msCD24 and cultured on collagen rafts for 11 days. HIV infection kinetics were measured using snLuc. HIV-1 infected and uninfected cells were characterized using a 28-color flow cytometry panel: CD45, CD14, CD11c, CD3, TCR-αβ, CD4, CD8, CCR5, CXCR4, α4β7, CD45RA, CCR7, CD68, CD206, CD163, CD209, CD207, CD169, HLA-DR, CD80/86, CD38, BST-2, IFNγ, TNFα, IL-10 and msCD24. Culture supernatants were also collected from uninfected, unstimulated CETs to assess “baseline” cytokine and chemokine profiles using Luminex.
Results
CD4+ T cells were of the effector memory phenotype in both TGM (95.08% ± 0.54%) and CIS CETs (87.52% ± 0.10%), although CXCR4+CCR5+ expression was profound in TGM (28.71% ± 0.23%) compared to CIS (6.79% ± 0.12%; p=0.0006). Similarly, the frequency of α4β7+CCR5+CXCR4+CD4Tem (p=0.0103) and CD38+CD8+ T cells (p=0.0066) was higher in TGM compared to CIS. Similar trends were observed, in the CD206+CD163+ macrophages dominating the TGM macrophage compartment, although the expression of BST-2 and IFNy was downregulated in TGM. Interestingly, IFNα, CXCL10 and IL-1α, were elevated in TGM compared to CIS CETs culture supernatants. Collectively these findings alluded to increased HIV-1 acquisition risk, as shown by increased HIV-1 replication kinetics in TGM CETs compared to CIS CETs
Conclusions
Taken together, our findings suggest increased susceptibility to HIV-1 infection, consistent with testosterone administration